Aura Biosciences AURA
NASDAQ AURA
$7.48 +0.11 (+1.49%)
As of: Sep 4, 2026 · 12:48 PM EDT

Aura Biosciences (AURA) Other Non Operating Income (2021 - 2026)

Aura Biosciences' (AURA) quarterly Other Non Operating Income came in at $2000.0 in Q1 2026, up 108.33% YoY from $960.0 in Q1 2025, and down 98.66% on a QoQ basis from $149000.0 in Q4 2025.

Analysis

Aura Biosciences (AURA) Other Non Operating Income (2021 - 2026) Analysis & Trends

Aura Biosciences (AURA) has 6 years of Other Non Operating Income data on file, last reported at $2000.0 in Q1 2026.

  • Quarterly Other Non Operating Income rose 108.33% year-over-year to $2000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $102000.0 (up 191.07% YoY) and the FY2025 annual result came in at $77000.0, up 164.17% from the prior year.
  • Other Non Operating Income fell to $2000.0 in Q1 2026, from $149000.0 in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $310000.0 in Q4 2022 to a low of -$329000.0 in Q3 2022.
  • A 5-year average of -$7352.9 and a median of -$25000.0 in 2024 frame the typical range for Other Non Operating Income.
  • Annual changes were most pronounced in 2022 — Other Non Operating Income sank 732.69% — and 2025, when it jumped 502.7%.
  • Tracing AURA's Other Non Operating Income over 5 years: stood at $310000.0 in 2022, then slumped by 108.39% to -$26000.0 in 2023, then sank by 42.31% to -$37000.0 in 2024, then jumped by 502.7% to $149000.0 in 2025, then tumbled by 98.66% to $2000.0 in 2026.
  • The last three Other Non Operating Income figures came in at $2000.0 (Q1 2026), $149000.0 (Q4 2025), and -$13000.0 (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.62 Bn 131.77 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.73 Bn 77.73 Bn 3.93 Bn
3 Argenx Se 63.53 Bn 58.35 Bn 1.37 Bn
4 Moderna 58.23 Bn 53.09 Bn 52.00 Mn
5 Revolution Medicines 44.05 Bn 44.05 Bn -
6 BeOne Medicines 40.03 Bn 34.93 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.50 Bn 32.19 Bn 992.69 Mn
8 Royalty Pharma 28.52 Bn 27.68 Bn -
9 Insmed 27.46 Bn 26.30 Bn 358.27 Mn
10 Aura Biosciences 709.58 Mn 641.74 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 154,000.00
Mar 31, 2026 2,000.00
Dec 31, 2025 -2.66 Mn
Sep 30, 2025 -13,000.00
Jun 30, 2025 -36,000.00
Mar 31, 2025 -24,000.00
Dec 31, 2024 3.17 Mn
Sep 30, 2024 -25,000.00
Jun 30, 2024 -26,000.00
Mar 31, 2024 -32,000.00
Dec 31, 2023 -26,000.00
Sep 30, 2023 -5,000.00
Jun 30, 2023 -32,000.00
Mar 31, 2023 -13,000.00
Dec 31, 2022 310,000.00
Sep 30, 2022 -329,000.00
Jun 30, 2022 56,000.00
Mar 31, 2022 -44,000.00
Sep 30, 2021 52,000.00
Jun 30, 2021 52,000.00